Supiot S - Search Results

1

microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation.

Labbé M, Hoey C, Ray J, Potiron V, Supiot S, Liu SK, Fradin D. Labbé M, et al. Among authors: supiot s. Mol Cancer. 2020 Mar 23;19(1):63. doi: 10.1186/s12943-020-01186-6. Mol Cancer. 2020. PMID: 32293453 Free PMC article. Review.

2

Nutlin-3 radiosensitizes hypoxic prostate cancer cells independent of p53.

Supiot S, Hill RP, Bristow RG. Supiot S, et al. Mol Cancer Ther. 2008 Apr;7(4):993-9. doi: 10.1158/1535-7163.MCT-07-0442. Mol Cancer Ther. 2008. PMID: 18413812 Free article.

3

Targeting homologous recombination using imatinib results in enhanced tumor cell chemosensitivity and radiosensitivity.

Choudhury A, Zhao H, Jalali F, Al Rashid S, Ran J, Supiot S, Kiltie AE, Bristow RG. Choudhury A, et al. Among authors: supiot s. Mol Cancer Ther. 2009 Jan;8(1):203-13. doi: 10.1158/1535-7163.MCT-08-0959. Mol Cancer Ther. 2009. PMID: 19139130 Free article.

4

[Surveillance after prostate cancer radiotherapy].

Supiot S, Rio E, Clément-Colmou K, Bouchot O, Rigaud J. Supiot S, et al. Cancer Radiother. 2011 Oct;15(6-7):540-5. doi: 10.1016/j.canrad.2011.05.005. Epub 2011 Jul 26. Cancer Radiother. 2011. PMID: 21795093 Review. French.

5

[Radiobiology dedicated to endothelium].

Supiot S, Paris F. Supiot S, et al. Cancer Radiother. 2012 Feb;16(1):11-5. doi: 10.1016/j.canrad.2011.10.006. Epub 2012 Feb 10. Cancer Radiother. 2012. PMID: 22326117 Review. French.

6

Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions.

Potiron VA, Abderrahmani R, Giang E, Chiavassa S, Di Tomaso E, Maira SM, Paris F, Supiot S. Potiron VA, et al. Among authors: supiot s. Radiother Oncol. 2013 Jan;106(1):138-46. doi: 10.1016/j.radonc.2012.11.014. Epub 2013 Jan 12. Radiother Oncol. 2013. PMID: 23321494

7

[Hypofractionated radiotherapy in prostate cancer].

Supiot S, Créhange G, Latorzeff I, Pommier P, Paumier A, Rio E, Delaroche G, Guérif S, Catton C, Martin J, Lisbona A. Supiot S, et al. Cancer Radiother. 2013 Oct;17(5-6):349-54. doi: 10.1016/j.canrad.2013.05.005. Epub 2013 Aug 20. Cancer Radiother. 2013. PMID: 23973460 Review. French.

8

Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer.

Potiron VA, Abderrahmani R, Clément-Colmou K, Marionneau-Lambot S, Oullier T, Paris F, Supiot S. Potiron VA, et al. Among authors: supiot s. PLoS One. 2013 Dec 31;8(12):e84076. doi: 10.1371/journal.pone.0084076. eCollection 2013. PLoS One. 2013. PMID: 24391887 Free PMC article.

9

[Stereotactic body radiation therapy and oligometastases].

Bourgier C, Azria D, Fenoglietto P, Riou O, Almaghrabi MY, Supiot S, Mornex F, Giraud P. Bourgier C, et al. Among authors: supiot s. Cancer Radiother. 2014 Jul-Aug;18(4):337-41. doi: 10.1016/j.canrad.2014.02.008. Epub 2014 May 1. Cancer Radiother. 2014. PMID: 24792996 Review. French.

10

Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?

Créhange G, Roach M 3rd, Martin E, Cormier L, Peiffert D, Cochet A, Chapet O, Supiot S, Cosset JM, Bolla M, Chung HT. Créhange G, et al. Among authors: supiot s. Cancer Radiother. 2014 Oct;18(5-6):524-34. doi: 10.1016/j.canrad.2014.07.153. Epub 2014 Sep 2. Cancer Radiother. 2014. PMID: 25192626 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters